Skip to main content
. 2017 Feb 15;147(4):621–627. doi: 10.3945/jn.116.243279

TABLE 2.

The association of dietary and supplemental intake of selenium with ovarian cancer, African American Cancer Epidemiology Study, 2010–20141

Intake, μg/d Cases Controls 2 P-linear3
Dietary 0.1
 Q1 (<47.8) 88 (21.7) 158 (25.0) 1.00 Referent
 Q2 (47.8–72.6) 122 (30.0) 158 (25.0) 1.19 (0.74, 1.91)
 Q3 (72.7–111.7) 102 (25.1) 158 (25.0) 0.98 (0.54, 1.78)
 Q4 (>111.7) 94 (23.2) 158 (25.0) 0.66 (0.31, 1.37)
Supplemental 0.04
 T1 (nonconsumer) 203 (50.0) 274 (43.4) 1.00 Referent
 T2 (0–20.0) 139 (34.2) 211 (33.4) 0.89 (0.66, 1.21)
 T3 (>20.0) 64 (15.8) 147 (23.3) 0.67 (0.46, 0.97)*
Total 0.1
 Q1 (<60.9) 110 (27.1) 158 (25.0) 1.00 Referent
 Q2 (60.9–96.4) 120 (29.6) 158 (25.0) 0.91 (0.60, 1.38)
 Q3 (96.5–137.4) 76 (18.7) 158 (25.0) 0.58 (0.35, 0.94)*
 Q4 (>137.4) 100 (24.6) 158 (25.0) 0.67 (0.39, 1.14)
1

Values are n (%) unless otherwise indicated. Supplement or dietary counterpart as covariate was added when appropriate. *P < 0.05, different from the reference level. Q, quartile; T, tertile.

2

Adjusted for age, region, education, parity, oral contraceptive use, menopause, tubal ligation, family history, BMI, smoking status, total energy, and physical activity.

3

P-linear is for a test of linear trend treating quartile and tertile medians as a continuous variable.